Search Results - clinical+and+disease+specializations+%3e+hematology+%3e+sickle+cell+disease

1 Results

Sort By:

C05053: Small Molecules Epigenetic Inhibitors for Cancer Prevention and Treatment.

C05053: Small Molecules Epigenetic Inhibitors for Cancer Prevention and Treatment.Value Proposition: • Compounds represent first in class small molecule agents for inhibition of MBD2 activity. • Reversible inhibition. • Truly epigenetic agents, unlike other epigenetic drugs which appear to have cytotoxic effects independent of epigenetic...

Published: 3/13/2025 | Inventor(s): Xiaohui Lin, Zachery Reichert, Traci Speed, Srinivasan Yegnasubramanian, William Nelson

Keywords(s): Antagonists/Inhibitors, Cancers, Disease Indication, Genetic Disorders, Non-novel, Off-the-shelf, Predicted Novelty, Sickle Cell Anemia, Single, Small Molecules, Targeted Therapy, Therapeutic Matter, Therapeutic Substance, Therapeutics, Therapy Type

Category(s): Clinical and Disease Specializations, Clinical and Disease Specializations > Oncology, Technology Classifications > Therapeutic Modalities > Small Molecules, Technology Classifications > Therapeutic Modalities > Targets, Technology Classifications > Therapeutic Modalities, Clinical and Disease Specializations > Hematology > Sickle Cell Disease